This week’s episode is our 2023 update of the treatment landscape of early stage and locally advanced Non-Small Cell Lung Cancer (NSCLC). We will cover important details on pathology, staging, local and systemic therapy options, and special scenarios. 

This week’s episode will be focusing on some of the most testable thrombophilia syndromes including Antiphospholipid Syndrome, Antithrombin III deficiency, Protein C and S deficiency, Factor V Leiden, and Prothrombin mutations. We will go over important details on the presentation, diagnostic testing, and treatment.

This week’s episode  is part 2 of 2023 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status.

We are continuing our 2023 updates, this week’s episode will be an intro to breast cancer. Today’s will include high yield tips on screening, prevention, ductal carcinoma in situ DCIS, lobular carcinoma in situ LCIS, as well as introduce invasive localized disease.

This week’s episode is a quick one, focusing on heparin induced thrombocytopenia (HIT). We will go over the the pathophysiology, diagnosis and treatment of HIT.

This week’s episode will be focusing on Hematopoietic Stem Cell Transplant. We will go over the important details on the different types of SCT, where stem cells can be collected from, conditioning regimens as well as complications to be aware of for boards. This is a robust field so remember by no means is this short episode all of SCT but rather a quick overview for highest yield information for boards

Today’s episode is covering the treatment options for M0 castrate resistant prostate cancer as well as metastatic castrate-sensitive and castrate-resistant prostate cancer, including some 2023 updates.

Today’s episode is a 2023 update on the management of metastatic colon cancer. This will include an overview of molecular studies, treatment options and their toxicities.